Francesca Maestrelli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Venues

Pharmaceutics

Antioxidants (Basel, Switzerland)

Marine drugs

International journal of molecular sciences

University of Florence

University of Florence (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florence Jul 01 2015

Italy

Associate Professor :: Chemistry

University of Florence Jan 01 2005

Italy

Assistant Professor :: Chemistry

Education History

University of Florence Apr 01 2001 - Apr 15 2004

Italy

PHD :: Chemistry

Publications

Francesca Maestrelli, Marzia Cirri, Natascia Mennini, Silvia Fiani, Beatrice Stoppacciaro, Paola Angela Mura
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins. Pharmaceutics 16 (5) (2024)
Ilaria Chiarugi, Diletta Biagi, Paolo Nencioni, Francesca Maestrelli, Maurizio Valleri, Paola Angela Mura
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate. Pharmaceutics 16 (2) (2024)
Ilaria Chiarugi, Diletta Biagi, Paolo Nencioni, Francesca Maestrelli, Maurizio Valleri, Paola Angela Mura
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate. Pharmaceutics 16 (2) (2024)
Francesca Maestrelli, Marzia Cirri, Natascia Mennini, Silvia Fiani, Beatrice Stoppacciaro, Paola Angela Mura
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins. Pharmaceutics 16 (5) (2024)
Giulia Nerli, Lidia Maria Goncalves, Marzia Cirri, António José Almeida, Francesca Maestrelli, Natascia Mennini, Paola Angela Mura
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use. Pharmaceutics 15 (4) (2023)
Giulia Nerli, Lidia Maria Goncalves, Marzia Cirri, António José Almeida, Francesca Maestrelli, Natascia Mennini, Paola Angela Mura
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use. Pharmaceutics 15 (4) (2023)
Giulia Nerli, Lidia Maria Goncalves, Marzia Cirri, António José Almeida, Francesca Maestrelli, Natascia Mennini, Paola Angela Mura
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use. Pharmaceutics 15 (4) (2023)
Giulia Nerli, Lidia Maria Goncalves, Marzia Cirri, António José Almeida, Francesca Maestrelli, Natascia Mennini, Paola Angela Mura
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use. Pharmaceutics 15 (4) (2023)
Francesca Maestrelli, Marzia Cirri, Enrico De Luca, Diletta Biagi, Paola Angela Mura
Role of Cyclodextrins and Drug Solid State Properties on Flufenamic Acid Dissolution Performance from Tablets. Pharmaceutics 14 (2) (2022)
Paola Angela Mura, Francesca Maestrelli, Marzia Cirri, Natascia Mennini
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review. Marine drugs 20 (5) (2022)
Marzia Cirri, Giulia Nerli, Natascia Mennini, Francesca Maestrelli, Paola Angela Mura
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System. Pharmaceutics 14 (12) (2022)
Marzia Cirri, Giulia Nerli, Natascia Mennini, Francesca Maestrelli, Paola Angela Mura
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System. Pharmaceutics 14 (12) (2022)
Marzia Cirri, Giulia Nerli, Natascia Mennini, Francesca Maestrelli, Paola Angela Mura
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System. Pharmaceutics 14 (12) (2022)
Marzia Cirri, Giulia Nerli, Natascia Mennini, Francesca Maestrelli, Paola Angela Mura
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System. Pharmaceutics 14 (12) (2022)
Marzia Cirri, Francesca Maestrelli, Giulia Nerli, Natascia Mennini, Mario D'Ambrosio, Cristina Luceri, Paola Angela Mura
Development of a Cyclodextrin-Based Mucoadhesive-Thermosensitive In Situ Gel for Clonazepam Intranasal Delivery. Pharmaceutics 13 (7) (2021)
Emanuela Berrino, Simone Carradori, Andrea Ageli, Fabrizio Carta, Claudiu T Supuran, Paolo Guglielmi, Cecilia Coletti, Roberto Paciotti, Helmut Schweikl, Francesca Maestrelli, Elisabetta Cerbai, Marialucia Gallorini
Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages. Antioxidants (Basel, Switzerland) 10 (1) (2021)
Paola Angela Mura, Francesca Maestrelli, Marzia Cirri, Giulia Nerli, Di Cesare Mannelli Lorenzo, Carla Ghelardini, Natascia Mennini
Improvement of Butamben Anesthetic Efficacy by the Development of Deformable Liposomes Bearing the Drug as Cyclodextrin Complex. Pharmaceutics 13 (6) (2021)
Ana-María Fernández-Romero, Francesca Maestrelli, Sara García-Gil, Elena Talero, Paola Angela Mura, Antonio M Rabasco, María Luisa González-Rodríguez
Preparation, Characterization and Evaluation of the Anti-Inflammatory Activity of Epichlorohydrin-β-Cyclodextrin/Curcumin Binary Systems Embedded in a Pluronic ® /Hyaluronate Hydrogel. International journal of molecular sciences 22 (24) (2021)
Marzia Cirri, Natascia Mennini, Giulia Nerli, Jessica Rubia, Enrico Casalone, Fabrizio Melani, Francesca Maestrelli, Paola Angela Mura
Combined Use of Cyclodextrins and Amino Acids for the Development of Cefixime Oral Solutions for Pediatric Use. Pharmaceutics 13 (11) (2021)
Paola Angela Mura, Francesca Maestrelli, Mario D'Ambrosio, Cristina Luceri, Marzia Cirri
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations. Pharmaceutics 13 (4) (2021)
Damiano Cirri, Ida Landini, Lara Massai, Enrico Mini, Francesca Maestrelli, Luigi Messori
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study. Pharmaceutics 13 (5) (2021)
Yasamin Soleimanian, Sayed Amir Hossein Goli, Jaleh Varshosaz, Di Cesare Mannelli Lorenzo, Carla Ghelardini, Marzia Cirri, Francesca Maestrelli
β-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity. Pharmaceutics 12 (4) (2020)
Francesca Maestrelli, Elisa Landucci, Enrico De Luca, Giulia Nerli, Maria Camilla Bergonzi, Vieri Piazzini, Domenico E Pellegrini-Giampietro, Francesca Gullo, Andrea Becchetti, Francesco Tadini-Buoninsegni, Oscar Francesconi, Cristina Nativi
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain. Pharmaceutics 11 (12) (2019)
Marzia Cirri, Francesca Maestrelli, Paola Angela Mura, Carla Ghelardini, Lorenzo Di Cesare Mannelli
Combined Approach of Cyclodextrin Complexationand Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide. Pharmaceutics 10 (4) (2018)
Ana-María Fernández-Romero, Francesca Maestrelli, Paola Angela Mura, Antonio María Rabasco, María Luisa González-Rodríguez
Novel Findings about Double-Loaded Curcumin-in-HPβcyclodextrin-in Liposomes: Effects on the Lipid Bilayer and Drug Release. Pharmaceutics 10 (4) (2018)

Francesca Maestrelli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesca Maestrelli